Tamtam Try Tamtam free
Corbion logo

Corbion account plan

Leading supplier of sustainable food preservation solutions

At a glance

Corbion is a Dutch fermentation-based food-ingredient company (lactic acid, natural preservation, algae omega-3) with € 1,267.4 million sales in 2025.

Corbion is a Euronext Amsterdam-listed company that makes food-ingredient solutions from fermentation: lactic acid and derivatives, natural food preservation, functional ingredient systems and algae-derived omega-3. It sells to food manufacturers, industrial, pharma and medical customers through sales offices and distributors, with plants in the US, Thailand, Brazil, Mexico, the Netherlands and Spain and headquarters in the Netherlands. In 2025 sales were € 1,267.4 million (+2.2% organic), adjusted EBITDA € 204.3 million (16.1% margin) and result after taxes € 74.8 million, with a workforce of 2,408 FTE. The US was its largest market at € 460.7 million of sales.

Business units

Strategic priorities

BRIGHT 2030 targets
Announced in November 2025: 3-6% organic sales growth per year, adjusted EBITDA margin of approximately 18% by 2028, € 270 million cumulative free cash flow over 2026-2028 and 13% ROCE.
Natural and label-friendly preservation
Grow in natural mold inhibitors, vinegars and Listeria control (with AI-driven modeling) as customers reformulate and EU Listeria legislation tightens in summer 2026; the report sizes the natural food preservation market at € 1.6 billion, growing 4-5% a year.
Omega-3 beyond aquaculture
Diversify algae omega-3 into pet food, human nutrition and products such as astaxanthin, and renegotiate long-term aquaculture contracts ending in December 2026 at higher prices.
Grow Biomaterials
Expand resorbable polymers in drug delivery, orthopedics and aesthetics, supported by the WELTRUZA approval.
Margin through input costs and mix
Levers to an 18% margin are input costs (sugar hedged for 2027 and early 2028), faster growth in H&N specialties and returns on the Thai lactic acid plant, while reducing non-core lactic acid exposures.

Latest results

In Q3 2026 sales were € 340.5 million (+9.3% reported, +7.6% organic) and adjusted EBITDA € 64.1 million, a margin of 18.8% versus 15.9% a year earlier. Health & Nutrition grew 20.0% organically in the quarter as Nutrition volumes phased from the first half came through and higher fish oil prices lifted omega-3 DHA prices. For the first nine months, sales were € 971.6 million (+3.9% organic), adjusted EBITDA € 152.9 million (15.7% margin) and free cash flow € 57 million. Guidance was maintained at +3-6% organic sales growth, adjusted EBITDA margin above 16% (cut in July from around 17% on Middle East-driven sulfuric acid costs) and free cash flow of € 85-90 million.

Investments and deals

Algae oil capacity in Brazil
The Orindiúva capacity expansion is complete and a new fermenter adds capacity in 2027; a decision on debottlenecking or a brownfield investment is due by end-2026.
Food footprint expansion
Expanded fermentation and vinegar capacity in Montgomery (US), new dairy and bakery labs, a fully operational Querétaro (Mexico) facility, and application capabilities in Singapore and India.
Capex plan
Capex was € 68.5 million in 2025, mainly Nutrition capacity and vinegar insourcing; the 2026 plan was about € 85 million.
Innovation partnerships and botanicals
Partnerships with BRAIN Biotech, Kuehnle AgroSystems and Phycom, and an intent to add botanical extraction technologies such as rosemary extracts.
PLA joint venture stake kept
The sale of the TotalEnergies Corbion stake started after November 2025 was ended in October 2026; Corbion will keep developing the business.

Challenges and risks

Middle East input costs
Higher sulfuric acid costs have a gross impact of €15 million to €20 million in 2026 and are expected to stay elevated in 2027.
Soft core food demand
Bakery and meat demand stayed soft, and after SNAP support was withdrawn US customers asked for more affordable recipes.
Lactic acid competition
Global imbalances of lactic acid supply and demand are a top risk, alongside raw material and energy price volatility (sugar is 28% of raw material spend).
Geopolitics, tariffs and currency
Tariffs and inflation are top risks; a 1% depreciation of the US dollar against the euro reduces EBITDA by about € 2.4 million.
Customer concentration in omega-3
A few large aquaculture customers drive Nutrition volumes, which caused weak Q1 2026 phasing.

What leadership says

“our natural preservation platform continues to win. Especially as customers look for cleaner label, regulation-ready solutions.”

Olivier Rigaud, CEO · Q2/H1 2026 results call, 31 July 2026

“why we are pushing hard to grow beyond aquaculture into pet nutrition and human nutrition.”

Olivier Rigaud, CEO · FY/Q4 2025 results call, 26 February 2026

“I am proud to report that our team delivered strong results, reflecting the high demand for our portfolio and disciplined execution across the businesses.”

Olivier Rigaud, CEO · Q3 2026 Interim Management Statement, 28 October 2026

“predominantly driven by the Middle East situation”

Peter Kazius, CFO · Q2/H1 2026 results call, 31 July 2026, on the margin guidance cut

Where a supplier can help

Alternative inputs and procurement
Tied to the Middle East input-cost challenge: suppliers of sulfuric acid alternatives, energy or commodity risk tools can help protect the 2026 margin guidance.
Fermentation and refining capacity
Tied to the algae oil capacity decision and Brazil fermenter: engineering, bioprocess equipment and refining suppliers fit the debottlenecking or brownfield choice.
Food safety and modeling tools
Tied to the natural preservation priority and Listeria regulation: lab, testing and data-modeling partners can support application development for customers.
Pet and human nutrition channels
Tied to diversifying omega-3 beyond aquaculture: distributors and formulators in pet food and supplements can open new customers.
Application labs in growth regions
Tied to the food footprint expansion in Mexico, Singapore and India: lab equipment and service providers can support new application capabilities.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Corbion?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Corbion

What does Corbion do?

Corbion makes fermentation-based ingredients: lactic acid and derivatives, natural food preservation systems, algae omega-3 for aquaculture, pets and people, pharma ingredients and resorbable biomaterials.

What is Corbion's revenue?

Corbion's 2025 sales were € 1,267.4 million with adjusted EBITDA of € 204.3 million; sales for the first nine months of 2026 were € 971.6 million.

How many employees does Corbion have?

Corbion had a workforce of 2,408 FTE at the end of 2025.

Who leads Corbion?

Olivier Rigaud has been CEO since August 2019, with Peter Kazius as CFO since May 2024; the Supervisory Board is chaired by Ilona Haaijer.

What is Corbion's strategy?

BRIGHT 2030 focuses on natural preservation, nutrition and biomaterials, targeting 3-6% organic sales growth a year and an adjusted EBITDA margin of approximately 18% by 2028.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)